Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Randomized Controlled Trial of Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer

NCT01587534 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT01587534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01587534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Randomized Controlled Trial of Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer
Lead sponsor
National Cancer Center, Korea
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2014
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer